CD8A and neoplasm: Flow cytometric analysis revealed a significant, dose-dependent increase in tumor cell apoptosis following CEP pretreatment (Figure 2B,C), indicating enhanced susceptibility of tumor cells to CD8+ T cell-mediated killing.